";s:4:"text";s:5367:" {* mergePassword *} {* #userInformationForm *} {* acknowledgement_consent *} The use of Premarin Intravenous does not preclude the advisability of other appropriate measures. (See The Women's Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50 to 79 years of age) during 7.1 years of treatment with daily oral conjugated estrogens (CE) [0.625 mg]-alone, relative to placebo. 0000002042 00000 n
{* socialRegistration_emailAddress *} (See WARNINGS, Malignant neoplasms, Endometrial cancer.) 0000003894 00000 n
The WHI estrogen plus progestin substudy stratified by age showed in women 50 to 59 years of age a non-significant trend toward reduced risk for overall mortality [HR 0.69 (95 percent CI, 0.44–1.07)].The WHIMS estrogen-alone ancillary study of WHI enrolled 2,947 predominantly healthy postmenopausal women 65 to 79 years of age and older (45 percent were 65 to 69 years of age; 36 percent were 70 to 74 years of age; 19 percent were 75 years of age and older) to evaluate the effects of daily CE (0.625 mg)-alone on the incidence of probable dementia (primary outcome) compared to placebo.After an average follow-up of 5.2 years, the relative risk of probable dementia for CE-alone versus placebo was 1.49 (95 percent CI, 0.83–2.66). 0000010380 00000 n
Among women who reported no prior use of hormone therapy, the relative risk of invasive breast cancer was 1.09, and the absolute risk was 40 versus 36 cases per 10,000 women-years for CE plus MPA compared with placebo. {*#userInformationForm*} A “global index” included the earliest occurrence of CHD, invasive breast cancer, stroke, pulmonary embolism (PE), endometrial cancer (only in the CE plus MPA substudy), colorectal cancer, hip fracture, or death due to other causes. The estrogen-alone substudy did not report a statistically significant effect on death due to other causes (RR 1.08, 95% nCI 0.88-1.32) or an effect on overall mortality risk (RR 1.04, 95% nCI 0.88-1.22). Reconstitute Premarin Intravenous with 5 mL of Sterile Water for Injection, USP. Use immediately after reconstitution. Women with normal thyroid function can compensate for the increased TBG by making more thyroid hormone, thus maintaining free TEstrogens may cause some degree of fluid retention. Premarin. Appropriate investigations should be arranged at regular intervals as determined by the physician.The results of certain endocrine and liver function tests may be affected by estrogen-containing products:The results of the above laboratory tests may not be reliable unless therapy has been discontinued for two to four weeks. {* traditionalSignIn_emailAddress *} To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.Premarin Intravenous for injection contains a mixture of conjugated estrogens, which are a mixture of sodium estrone sulfate and sodium equilin sulfate and other components including sodium sulfate conjugates: 17α-dihydroequilin, 17α-estradiol, and 17β-dihydroequilin. Lipid-lowering measures are recommended additionally, before treatment is started.Premarin Intravenous should not be used during pregnancy (see Estrogen administration to nursing mothers has been shown to decrease the quantity and quality of breast milk. For women known to have residual endometriosis post-hysterectomy, the addition of progestin should be considered.Estrogen therapy may cause an exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, and hepatic hemangiomas and should be used with caution in women with these conditions.Physicians are advised to discuss the contents of the Estrogen administration should be guided by clinical response at the lowest dose, rather than laboratory monitoring.Long-term continuous administration of natural and synthetic estrogens in certain animal species increases the frequency of carcinomas of the breast, uterus, cervix, vagina, testis, and liver.Premarin Intravenous should not be used during pregnancy. {* salutation *}